|
|
|
Cardiology
Clinical significance of high on-treatment platelet reactivity in patients with prolonged clopidogrel therapy
Sehun Kim, Donghoon Han, Jae Hyuk Choi, Eun-Joo Park, Dong Geum Shin, Min-Kyung Kang, Seonghoon Choi, Namho Lee, Jung Rae Cho
Korean J Intern Med. 2021;36(Suppl 1):S80-S89. Published online February 25, 2021
Background/Aims: Prolonged dual antiplatelet therapy (DAPT) with aspirin and clopidogrel beyond 1 year has been shown to reduce ischemic events at the expense of increased bleeding. However, limited data are available on the clinical significance of platelet reactivity (PR) at 1 year.
Methods: We r..
|
|
|
2018 Guidelines for the management of dyslipidemia in Korea
Eun-Jung Rhee, Hyeon Chang Kim, Jae Hyeon Kim, Eun Young Lee, Byung Jin Kim, Eun Mi Kim, YoonJu Song, Jeong Hyun Lim, Hae Jin Kim, Seonghoon Choi, Min Kyong Moon, Jin Oh Na, Kwang-Yeol Park, Mi Sun Oh, Sang Youb Han, Junghyun Noh, Kyung Hee Yi, Sang-Hak Lee, Soon-Cheol Hong, In-Kyung Jeong; on behalf of the Committee of Clinical Practice Guideline of Korean Society of Lipid and Atherosclerosis
Korean J Intern Med. 2019;34(5):1171-1171. Published online August 28, 2019
|
|
|
2018 Guidelines for the management of dyslipidemia
[corrected-article]
Eun-Jung Rhee, Hyeon Chang Kim, Jae Hyeon Kim, Eun Young Lee, Byung Jin Kim, Eun Mi Kim, YoonJu Song, Jeong Hyun Lim, Hae Jin Kim, Seonghoon Choi, Min Kyong Moon, Jin Oh Na, Kwang-Yeol Park, Mi Sun Oh, Sang Youb Han, Junghyun Noh, Kyung Hee Yi, Sang-Hak Lee, Soon-Cheol Hong, In-Kyung Jeong
Korean J Intern Med. 2019;34(4):723-771. Published online July 1, 2019
|
|
|
Cardiology
Clinical impact of routine follow-up coronary angiography after second- or third-generation drug-eluting stent insertion in clinically stable patients
Seonghoon Choi, Hee-Sun Mun, Min-Kyung Kang, Jung Rae Cho, Seong Woo Han, Namho Lee Lee
Korean J Intern Med. 2015;30(1):49-55. Published online December 30, 2014
Background/Aims: In the bare-metal stent era, routine follow-up coronary angiography (RFU CAG) was used to ensure stent patency. With the advent of drug-eluting stents (DESs) with better safety and efficacy profiles, RFU CAG has been performed less often. There are few data on the clinical impact of..
|
|
|
